Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Women who experience menopause before the age of 50 - and especially before the age of 45 - are more likely to develop fatty ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

According to an expert panel report, as against 14026 cases of alcohol-related liver ailments in 2014-19, the number ...

The three-member panel formed by Chief Minister N Chandrababu Naidu analysed health data from Arogyasri, a flagship scheme ...

According to an expert panel report, as against 14026 cases of alcohol-related liver ailments in 2014-19, the number ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Approximately 850 people underwent free liver scans this week at the RAI Amsterdam convention center, where the European ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...